상세 보기
SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)-The Korean Cancer Study Group LY22-07.
- Kim, Jung Sun;
- Lee, Gyeong-Won;
- Lee, Myungwon;
- Youk, Jeonghwan;
- Lee, Hyunjung;
- 외 5명
Citations
WEB OF SCIENCE
0- 제목
- SPECTRUM: Phase II study of tislelizumab plus pemetrexed in patients with relapsed or refractory (R/R) primary diffuse large B-cell lymphoma (DLBCL) of the central nervous system (CNS)-The Korean Cancer Study Group LY22-07.
- 저자
- Kim, Jung Sun; Lee, Gyeong-Won; Lee, Myungwon; Youk, Jeonghwan; Lee, Hyunjung; Lim, Sung-nam; Kim, Soyeon; Jeon, Yoon Kyung; Park, Chul-Kee; Kim, Tae Min
- 발행일
- 2026-06
- 유형
- Meeting Abstract
- 권
- 44
- 호
- 16_SUPPL
- 언어
- ENG
- 출판사
- LIPPINCOTT WILLIAMS & WILKINS
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X